Efficacy of ketotifen in bronchial asthma.
Ketotifen was administered orally during a period of three months to 30 patients suffering from bronchial asthma. It proved to be a strong antiasthmatic agent and the results obtained were positive, i.e.: Excellent in 21 patients (70%), very good in 3 patients (10%), Good in 1 patient (4%), Poor in 5 patients (16%), The drug was very well tolerated and no signs of drug toxicity were observed. It is concluded that ketotifen is a very effective and safe drug for the prevention of bronchial asthma.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000707:Anaphylaxis; D001249:Asthma / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005541:Forced Expiratory Volume; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008407:Mast Cells / Q000187:drug effects / Q000276:immunology; D008875:Middle Aged; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use*; D013876:Thiophenes / Q000494:pharmacology / Q000627:therapeutic use*
D006634:Histamine H1 Antagonists; D010880:Piperidines; D013876:Thiophenes